[ad_1]
Regarding the case of fake cancer drugs that happened at VN Pharma Company, on the afternoon of September 15, the Department of Security and Investigation, the Ministry of Public Security, said that they processed, arrested and detained Le Dinh Thanh, an official from the Hai Department. Ho Chi Minh City to clarify irresponsible behavior that causes serious consequences.
A source from the Department of Investigative Security said that the police are still investigating, clarifying the responsibilities of some people related to this case.
Le Dinh Thanh’s behavior was discovered by the authorities in the resolution process of the case Nguyen Minh Hung (former chairman of the board of directors and CEO of VN Pharma Company), Vo Manh Cuong (former director of Trading Co., Ltd. H&C maritime international) and accomplices in the sale of counterfeit drugs, which are drugs, occurred at VN Pharma Company in Ho Chi Minh City and other provinces and cities.
|
Sentence of the accused in the case of fake anticancer drugs at VN Pharma |
Previously, on September 18, 2019, the Department of Security and Investigation of the Ministry of Public Security issued a decision to irresponsibly prosecute the criminal case causing serious consequences that occurred in the Vietnam Drug Administration and other agencies and units. participates in the evaluation, approval, licensing and import clearance of curative drugs under the Helix Canada and Health 2000 Canada brand names.
This is the case of the results of the investigation to expand the violation related to the case of Nguyen Minh Hung and his accomplices. Due to the expiration of the investigation time of this case, the investigating agency has divided the case irresponsibly, causing serious consequences, in an independent case.
According to the file, the defendants in the case of import and sale of counterfeit medicines used false papers, false contracts, false stamps to falsify the file and present it to the Vietnam Drug Administration (the Ministry of Health) to obtain the license . Imported H-Capita (cancer treatment) under the Helix brand from Canada; At the same time, using expired licenses to forge purchase and sale contracts, appendices with foreign companies to increase the value of the batch of H-Capita drugs by many times, with the aim of selling high prices to the market, collecting illicit profits.
[ad_2]
